Navigation Links
Sanofi Pasteur Presents Pediatric Data on Investigational Quadrivalent Influenza Vaccine
Date:5/1/2012

SWIFTWATER, Pa., May 1, 2012 /PRNewswire/ -- Sanofi Pasteur, the vaccines division of Sanofi (EURONEXT: SAN and NYSE: SNY), announced today new Phase III data for its investigational quadrivalent influenza vaccine (QIV) in children 6 months through 8 years of age. This pediatric study evaluated the safety and immunogenicity of QIV compared to currently licensed Fluzone® (Influenza Virus Vaccine). Results of the study were presented today at the Annual Meeting of the Pediatric Academic Societies in Boston.

The data from this pediatric study of QIV support the results of prior studies in adults. The non-inferiority comparisons demonstrate that the addition of a fourth influenza strain (a second B strain) to the investigational vaccine does not adversely affect the safety and immunogenicity profiles of QIV compared to those of licensed Fluzone vaccine. 

"Fluzone vaccine is the only influenza vaccine licensed and available in the U.S. for use in children as young as 6 months of age along with formulations of Fluzone vaccine available for the full spectrum of the population through the oldest adults," said David Greenberg, M.D., Senior Director, U.S. Scientific and Medical Affairs, Sanofi Pasteur. "We believe that a quadrivalent Fluzone vaccine could provide an important public health benefit for people of all ages by providing coverage against an extra B virus strain of influenza. Influenza B is responsible for a substantial burden of disease and influenza-associated complications and hospitalizations in children."

Currently, seasonal influenza vaccines contain the three influenza virus strains anticipated to circulate in a given year based on global surveillance of influenza virus activity during the prior year. The annual trivalent inactivated influenza vaccine (TIV) formulation includes two A strains and one B strain. However, f
'/>"/>

SOURCE Sanofi Pasteur
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Sanofi to Acquire Pluromed, Inc., Expanding Its Presence in Biosurgery
2. NBA, American Diabetes Association and Sanofi US Tip Off 2012 Dribble to Stop Diabetes Campaign
3. Catalina Council Boy Scouts Partner With Sanofi US Tucson Research Center to Host First-Ever Chemistry Merit Badge Program
4. UCSF, Sanofi Collaborate to Find New Diabetes Cures
5. Sanofi Announces Court Ruling Granting Preliminary Injunction Against Synvisc-One® Competitor Product
6. Sanofi Pasteur Launches Nationwide Education Campaign to Help Parents Make Informed Decisions about Immunization
7. Sanofi and Regeneron Report Positive Preliminary Phase 2 Program Results for Anti-PCSK9 Antibody in Hypercholesterolemia
8. Sanofi Tops Pfizer as Number One for Global Pharma Sales
9. Sanofi Pasteur Presents New Data Confirming Fluzone® High-Dose (Influenza Virus Vaccine) Produces Higher Antibody Response in the Age 65+ Population
10. Sanofi Pasteur Presents Additional Data on Investigational Quadrivalent Influenza Vaccine
11. Walgreens Take Care Health Systems and Sanofi US Open On-site Medical Center and Pharmacy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2014)... 2014 According to a ... "Latin America Home Healthcare Market (By Device Types: ... Mobility Assist Devices and Medical Supplies; By Services: ... and Unskilled Home Healthcare Services) - Industry Analysis, ... 2020" the Latin American Home Healthcare market was ...
(Date:9/2/2014)... 2014 According to the new ... Analytical, Preparative), by Material (Metal, Glass, Plastic), by Application ... to 2018", published by MarketsandMarkets, the Chiral Chromatography Columns ... poised to grow at a CAGR of 5.2% from ... Browse 90 market data tables and 15 figures ...
(Date:9/2/2014)... , Sept. 2, 2014  Avanir Pharmaceuticals, Inc. (NASDAQ: ... present an overview of the company at the Morgan Stanley ... , Presentation date: Tuesday September 9, 2014 ... A live webcast and 30-day archive of this presentation will ... Avanir Pharmaceuticals, Inc. Avanir Pharmaceuticals, Inc. is a ...
Breaking Medicine Technology:Home Healthcare Market in Latin America Expected to Reach USD 17.5 Billion in 2020: Transparency Market Research 2Home Healthcare Market in Latin America Expected to Reach USD 17.5 Billion in 2020: Transparency Market Research 3Home Healthcare Market in Latin America Expected to Reach USD 17.5 Billion in 2020: Transparency Market Research 4Home Healthcare Market in Latin America Expected to Reach USD 17.5 Billion in 2020: Transparency Market Research 5Home Healthcare Market in Latin America Expected to Reach USD 17.5 Billion in 2020: Transparency Market Research 6Chiral Chromatography Column Market Worth $87.8 Million by 2018 2Chiral Chromatography Column Market Worth $87.8 Million by 2018 3Chiral Chromatography Column Market Worth $87.8 Million by 2018 4
... 15 Isis Pharmaceuticals, Inc. (Nasdaq: ISIS ), ... present a company overview at the 17th Annual NewsMakers in ... 11:00 a.m. ET at the Millennium Broadway Hotel & Conference ... of the presentation will be available on the "Investors & ...
... Md., Oct. 15 /PRNewswire-Asia/ -- Synutra International, Inc. (Nasdaq: ... in China and a producer, marketer and seller of ... that the Company will present at Citi,s Greater China ... the Grand Hyatt Macau.  Management is currently scheduled to ...
Cached Medicine Technology:
(Date:9/2/2014)... Medex Analytic Services is delighted to ... Coral Springs, Fla. due to their greater than forecasted ... for the 2014 year by distinguishing Medex in the ... a higher level of service and professionalism in the ... the industry has responded.” , The location of the ...
(Date:9/2/2014)... HealthDay Reporter TUESDAY, Sept. 2, 2014 (HealthDay ... behind the rising rates of type 2 diabetes, according to ... national surveys spanning from 1976 through 2010 to determine how ... by factors such as changing distribution of race, age and ... prevalence of diabetes in men rose from about 5 percent ...
(Date:9/2/2014)... (HealthDay News) -- Melatonin supplements did not reduce delirium ... new study found. Many older hospital patients experience ... disruption of their normal sleep-wake cycle. A lack of ... to delirium, but there has been little research into ... study included 378 patients, average age 84, who had ...
(Date:9/2/2014)... and marijuana may lead to different types of harmful ... analyzed 2007 to 2011 data gathered from more than ... used alcohol or marijuana at least once. The ... unsafe driving, damage to relationships with friends and romantic ... of alcohol, especially among females. On the ...
(Date:9/2/2014)... in locations with less intensive (and expensive) practice patterns ... that spare patients unnecessary and excessive medical care, according ... . , "Growing concern about the costs and harms ... ability to avoid the provision of unnecessary care," said ... and The Dartmouth Institute for Health Policy & ...
Breaking Medicine News(10 mins):Health News:Medex Analytic Services Announces New Location for Corporate Headquarters 2Health News:Obesity Fueling Rise in Diabetes Rates, Study Finds 2Health News:Obesity Fueling Rise in Diabetes Rates, Study Finds 3Health News:Booze, Pot Bad for Teens in Different Ways, Study Suggests 2Health News:Residency training predicts physicians' ability to practice conservatively 2
... WASHINGTON, Sept. 18 Americans believe that,providing medical care ... top of our nation,s priorities, in line with resolving ... a new nationwide survey. What,s,more, three-quarters of the public ... military veterans., And what do Americans think should ...
... identified specific damages to the brain that may occur when ... study in mice found that those animals that lived alone ... more damage to neurons in one part of the brain ... studies in humans have shown that socially isolated heart attack ...
... primarily for blind people places a layer of information technology ... interest along their path as they pass them. , The ... of Michigan. Researchers will present their work at two conferences ... A to point B. They learn to count steps if ...
... is almost always adenocarcinoma or signet ring cell carcinoma ... cell carcinoma. We report a patient with adenocarcinoma of ... This is the first reported case of gastric cancer ... to be published on 28 May 2008 in the ...
... numerous randomized clinical trials (RCT) have evaluated, and ... treatment regimens. Surgery remains standard care for early ... have also shown a survival benefit associated with ... patterns of care for these cancers. A study ...
... Introduced, MINNEAPOLIS, Sept. 17 Today ClearWay ... Board Members and,thanked outgoing members for their service ... and Executive Director of the Honeywell,Foundation as well ... affairs for Honeywell, was elected as the new ...
Cached Medicine News:Health News:Survey Shows Most Americans Want Government to Stand Up for Veterans 2Health News:Survey Shows Most Americans Want Government to Stand Up for Veterans 3Health News:Study suggests why heart attack victims do better with social support 2Health News:Study suggests why heart attack victims do better with social support 3Health News:New Bluetooth system orients blind and sighted pedestrians 2Health News:New Bluetooth system orients blind and sighted pedestrians 3Health News:How to treat gastroesophageal adenocarcinom patients? 2Health News:ClearWay Minnesota(SM) Board Approves New Officers 2Health News:ClearWay Minnesota(SM) Board Approves New Officers 3
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: